Levothyroxine and the risk of adverse pregnancy outcomes in women with subclinical hypothyroidism: a systematic review and meta-analysis
Abstract Background Levothyroxine replacement therapy may decrease the risk of adverse pregnancy outcomes among women with subclinical hypothyroidism (SCH). The aim of this study is to conduct a systematic review and meta-analysis to examine the risk of adverse pregnancy, perinatal, and early childh...
Main Authors: | Magnus Bein, Oriana Hoi Yun Yu, Sonia Marzia Grandi, Francesca Y. E. Frati, Ihab Kandil, Kristian B. Filion |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12902-021-00699-5 |
Similar Items
-
BENEFICIAL EFFECTS OF LEVOTHYROXINE IN THE TREATMENT OF SUBCLINICAL HYPOTHYROIDISM
by: Mulic Mersudin, et al.
Published: (2016-12-01) -
Use of levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom: A population‐based assessment
by: Ya‐Hui Yu, et al.
Published: (2021-10-01) -
Thyroid symptomatology across the spectrum of hypothyroidism and impact of levothyroxine supplementation in patients with severe primary hypothyroidism
by: Deep Dutta, et al.
Published: (2019-01-01) -
Levothyroxine for the Treatment of Subclinical Hypothyroidism and Cardiovascular Disease
by: Laura Y. Sue, et al.
Published: (2020-10-01) -
To Treat or Not to Treat Subclinical Hypothyroidism, What Is the Evidence?
by: Jan Calissendorff, et al.
Published: (2020-01-01)